References
- 1. Longo DL, Fauci AS, Harrison TR, Langford CA. Harrison’s gastroenterology and hepatology. New York; London: McGraw-Hill Medical; 2010.
- 2. Kumar V, Abbas AK, Aster JC, Robbins SL. Robbins basic pathology. 9th ed. Philadelphia, PA: Elsevier; 2013.
- 3. Barton JC, Edwards CQ, Acton RT. HFE gene: Structure, function, mutations, and associated iron abnormalities. Gene. 2015;574(2):179-92.10.1016/j.gene.2015.10.009666013626456104
- 4. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology. 2002;122(2):281-9.10.1053/gast.2002.3099211832443
- 5. Barton JC, McLaren CE, Chen WP, Ramm GA, Anderson GJ, Powell LW, et al. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes. Ann Hepatol. 2018;17(5):871-9.10.5604/01.3001.0012.3169636885830145563
- 6. Kalas MA, Chavez L, Leon M, Taweesedt PT, Surani S. Abnormal liver enzymes: A review for clinicians. World J Hepatol. 2021;13(11):1688-98.10.4254/wjh.v13.i11.1688863768034904038
- 7. Assi TB, Baz E. Current applications of therapeutic phlebotomy. Blood Transfus. 2014 Jan;12(Suppl 1):s75-83.
- 8. Porter JL, Rawla P. Hemochromatosis. 2022 Oct 9. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
- 9. Anderson ER, Shah YM. Iron homeostasis in the liver. Compr Physiol. 2013;3(1):315-3010.1002/cphy.c120016
- 10. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS, American Association for the Study of Liver D. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-43.10.1002/hep.24330314912521452290
- 11. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology. 1975;68(3):525-33.10.1016/S0016-5085(75)80092-8
- 12. Alexander J, Kowdley KV. HFE-associated hereditary hemochromatosis. Genet Med. 2009;11(5):307-13.10.1097/GIM.0b013e31819d30f219444013
- 13. Sebastiani G, Wilkinson N, Pantopoulos K. Pharmacological Targeting of the Hepcidin/Ferroportin Axis. Front Pharmacol. 2016;7:160.10.3389/fphar.2016.00160491455827445804